Video Introduction to Critical Decisions
Want a sneak peak into why I wrote Critical Decisions? Take a look at this 5 minute video. Feel free to send links to all your friends, so they won’t fall behind the times!
Want a sneak peak into why I wrote Critical Decisions? Take a look at this 5 minute video. Feel free to send links to all your friends, so they won’t fall behind the times!
My father is 92 years old, and I am beginning to wonder whether the best thing for his health would be to stay away from doctors. That’s because well intentioned physicians often expose their elderly patients to harmful and unnecessary services out of habit. That’s certainly the message I absorbed after reading a recent issue…
Andrews was easily the most anxious patient I took care of that month, a gray Michigan February (is there any other kind?) which I spent in the hospital caring for patients admitted to the general medical ward at the Ann Arbor Veterans Affairs Medical Center. (Andrews is a pseudonym, as are all the patients I blog about, unless…
Steve B. wasn’t going to be fooled twice. He’d recently seen an ear, nose, and throat specialist for a “tickle in the throat” that wouldn’t go away. He’d forked over a co-pay at check-in, but then the doctor said he needed “to put a scope down there” and check his throat. He later received a…
With health care costs rising, employers (and insurance companies) are increasingly asking consumers (aka “patients”) to have more “skin in the game”—to pay more out of pocket for their medical care. The Kaiser Family Foundation has a nice report on trends in health insurance deductibles. This picture shows the rise in these deductibles. That means:…
Healthcare markets are complex and confusing places. But one fact is simple and straightforward: all else equal, hospitals and emergency departments are a lot more expensive than outpatient clinics. Which makes it all the more bewildering that so many low income patients prefer hospitals over primary care clinics. Bewildering until now. Shreya Kangovi and colleagues…
A recent economic analysis concluded that patients with metastatic cancer value their treatments significantly more than regulators recognize, with many expensive new therapies looking like veritable bargains to most patients.
read more